Kyle Amber to Pemphigoid, Bullous
This is a "connection" page, showing publications Kyle Amber has written about Pemphigoid, Bullous.
Connection Strength
9.401
-
Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy. Br J Dermatol. 2023 Dec 20; 190(1):137-138.
Score: 0.866
-
Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibition. J Eur Acad Dermatol Venereol. 2023 11; 37(11):e1339-e1340.
Score: 0.841
-
Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms. Front Immunol. 2022; 13:912876.
Score: 0.783
-
The Immunogenetics of Autoimmune Blistering Diseases. Adv Exp Med Biol. 2022; 1367:173-212.
Score: 0.756
-
Gene expression profiling of laminin a3-blocked keratinocytes reveals an immune-independent mechanism of blistering. Exp Dermatol. 2022 04; 31(4):615-621.
Score: 0.751
-
Characterizing the proteome of bullous pemphigoid blister fluid utilizing tandem mass tag labeling coupled with LC-MS/MS. Arch Dermatol Res. 2022 Nov; 314(9):921-928.
Score: 0.729
-
A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita. Am J Clin Dermatol. 2020 Aug; 21(4):557-565.
Score: 0.685
-
Eosinophils in bullous pemphigoid. Panminerva Med. 2021 Sep; 63(3):368-378.
Score: 0.679
-
Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid. Autoimmun Rev. 2019 May; 18(5):526-534.
Score: 0.621
-
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clin Rev Allergy Immunol. 2018 Feb; 54(1):26-51.
Score: 0.576
-
Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma. J Dtsch Dermatol Ges. 2018 Feb; 16(2):196-198.
Score: 0.576
-
A case report of bullous pemphigoid associated with a melanoma and review of the literature. Melanoma Res. 2017 02; 27(1):65-67.
Score: 0.538
-
Is anti-BP180 IgE associated with clinical phenotype? A reply to 'Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid'. Arch Dermatol Res. 2016 Jan; 308(1):65-6.
Score: 0.495
-
Melanoma is associated with an increased risk of bullous pemphigoid: a large population-based longitudinal study. Arch Dermatol Res. 2022 Jan; 314(1):77-83.
Score: 0.179
-
The role of Dipeptidyl Peptidase-4 in cutaneous disease. Exp Dermatol. 2021 03; 30(3):304-318.
Score: 0.175
-
Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs. 2018 Oct; 78(15):1527-1548.
Score: 0.151